TRANSGENE SA

Transgene shares dip 0.59% to €0.68, falling 20% since last month’s close, amid mixed biotech sector moves and a 200‑day SMA at €0.79. Click for details.

Transgene’s share price slides below 52‑week low as the biotech misses clinical milestones, risking further erosion without a clear commercialization plan.